Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
ID: 357253Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357253

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-25-220.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a grant opportunity titled "Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children," aimed at advancing research on language development in children diagnosed with late talking after 18 months. This initiative encourages applicants to utilize existing datasets to identify patterns, predictors, and underlying factors related to late talking and its developmental outcomes, while promoting data sharing and secondary analysis. The total funding available is up to $275,000 over a two-year period, with a submission deadline of January 3, 2025. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-220.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-25-220-Full-Announcement.html
    PAR-25-220.html
    The National Institutes of Health (NIH) seeks grant applications under the funding opportunity titled "Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children" (PAR-25-220). This initiative, part of the NIH's Tackling Acquisition of Language in Kids (TALK) program, aims to explore the language development and delays in children diagnosed with late talking after 18 months. The R21 grant encourages leveraging existing datasets to identify patterns, predictors, and underlying factors related to late talking and associated developmental outcomes. Eligible applicants include higher education institutions and various organizations, with a total budget of up to $275,000 over two years, and a submission deadline of January 3, 2025. Proposals must enhance data sharing, secondary analysis, and utility improvement while maintaining participant confidentiality. A Plan for Enhancing Diverse Perspectives (PEDP) is required to promote inclusivity in research. Applications will undergo a rigorous peer review process based on significance, innovation, approach, and environment, among other criteria. This funding opportunity reflects a commitment to advancing knowledge on language development challenges among late talking children and promoting open science practices through data accessibility.
    Similar Opportunities
    Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancement and Innovation in Measurement of Language Development and Predictors," aimed at fostering community-engaged research that enhances the understanding of children's language development through culturally and linguistically responsive measures. Applicants are required to develop a Plan for Enhancing Diverse Perspectives (PEDP) and a Community Engagement (CE) plan, focusing on innovative tool development for assessing language capabilities across diverse populations and communicative contexts. The total funding available for projects is capped at $275,000 over a two-year period, with applications due by September 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-244.html.
    Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)" aimed at enhancing research on children's language development. This initiative encourages community-engaged research to identify novel environmental factors that support language skills in children, emphasizing the development of strengths-focused and culturally responsive measures. The NIH seeks to broaden the understanding of language development and impairment, aligning with its commitment to reducing health disparities and ensuring inclusivity in research. Interested applicants must submit proposals that include a Community Engagement Plan and a Plan for Enhancing Diverse Perspectives, with submission deadlines starting January 5, 2025. For further details, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-112.html.
    Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancement and Innovation in Measurement of Language Development and Predictors," aimed at fostering community-engaged research to enhance the understanding of language development in children. Applicants are required to submit a Community Engagement (CE) Plan and a Plan for Enhancing Diverse Perspectives (PEDP), which will be evaluated for scientific merit, with a focus on developing culturally and linguistically relevant assessment tools for diverse populations, particularly those from lower socioeconomic backgrounds. This grant, categorized under Income Security and Social Services, does not require cost-sharing and is open to a wide range of eligible applicants, including various educational institutions and community organizations. Interested parties should note that the application deadline is September 7, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity for low-risk clinical trials in communication disorders under Funding Opportunity Number PAR-24-051. This initiative aims to support investigator-initiated projects that develop effective interventions in areas such as hearing, speech, and language, specifically targeting low-risk clinical trials that do not require FDA oversight and adhere to budget limits of under $500,000 in direct costs per year. The funding is particularly significant for enhancing research in communication disorders, ultimately improving public health outcomes through scientifically validated interventions. Interested applicants can submit proposals starting January 5, 2024, with the opportunity closing on January 8, 2028; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)" aimed at expanding knowledge of disorders that are currently or may become part of statewide newborn screening programs. This initiative seeks to gather comprehensive data on the natural history of these conditions to facilitate appropriate interventions for affected infants, improve diagnostic accuracy, and support the development of targeted treatments. The funding will assist in identifying biological mechanisms, understanding genetic diversity, and establishing data collection systems for longitudinal studies, emphasizing the importance of research in newborn screening. Interested applicants, including various educational and community organizations, can submit proposals with a maximum project period of five years, with the funding cycle opening on January 5, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-227.html.
    Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)" aimed at advancing precision medicine for pregnant individuals, lactating persons, and children. This grant seeks to support innovative research that develops novel tools and technologies, enhances understanding of drug mechanisms, and improves therapeutic options for these populations, particularly those with disabilities. The initiative is part of the R21 Exploratory/Developmental Research Grants program, with a funding cap of $275,000 over a potential two-year period, and requires a Data Management and Sharing Plan as part of the application process. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for May 7, 2026.
    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)" aimed at promoting research and development of novel screening methods and therapeutic interventions for conditions identified through newborn screening. This initiative encourages innovative projects that generate preliminary data on both existing and potentially fatal genetic disorders, emphasizing the importance of early detection and intervention. The program is open to a wide range of eligible applicants, including higher education institutions, nonprofits, and governmental bodies, with a total funding ceiling of $275,000 over two years. Interested applicants should note that the submission deadlines begin on January 16, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Schizophrenia and Related Disorders During Mid- to Late-Life" (PAR-24-026), aimed at advancing research on the onset and progression of schizophrenia and related disorders in individuals aged 35 and older. This initiative seeks to promote high-risk exploratory and developmental projects that investigate neurobiological, psychosocial, and environmental factors contributing to these disorders, with a particular emphasis on addressing health disparities among minority and aging populations. The program offers a maximum funding amount of $275,000 over two years, with applications due by November 16, 2023, for the initial cycle. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering small research grants under the Gabriella Miller Kids First Pediatric Research Program, aimed at analyzing genomic and phenotypic data related to childhood cancers and structural birth defects. This funding opportunity encourages innovative research projects that utilize Kids First data, with a focus on developing analytical approaches, tools, or algorithms to enhance understanding and treatment of pediatric conditions. The initiative is part of a broader effort to leverage genomics for precision medicine in pediatric healthcare, with a maximum funding amount of $200,000 available for projects lasting up to two years. Interested applicants can find more information and apply by visiting the program's webpage or contacting NIH Grants Information at grantsinfo@nih.gov, with applications due by January 7, 2026.
    Data Sharing for Demographic Research Infrastructure Program
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Data Sharing for Demographic Research Infrastructure Program," aimed at supporting a repository for datasets produced through the Population Dynamics Branch (PDB) and other components of NICHD’s Division of Extramural Research. The initiative seeks to enhance data archiving, curation, and dissemination services, ensuring compliance with NIH data sharing requirements while providing unique resources for researchers, including best practices for sharing sensitive data. The grant has a total funding amount of $600,000, with a single award expected, and interested applicants can reach out to Randolph Capps at Randy.Capps@NIH.gov or by phone at 240-619-9856. Key deadlines include an estimated synopsis close date of July 22, 2026, and an anticipated award date of April 1, 2027.